Category - Feature

Feature

Diffusion Pharma readies pivotal hypoxic GBM trial

By Len Zehr Diffusion Pharmaceuticals (NASDAQ:DFFN) expects to begin before the end of 2017 a pivotal clinical trial with its trans sodium crocetinate (TSC) lead compound to re-oxygenate oxygen-deprived tissue in...

October 3, 2017

Feature

In conversation with Hrishikesh Suresh of NeuroGate

By Len Zehr As CEO and one of three co-founders of upstart NeuroGate, Hrishikesh Suresh currently is completing his final year as a medical student at McMaster University in Hamilton, Ontario and plans to pursue a six...

September 26, 2017

Feature

American CryoStem pioneering adipose tissue stem cell technologies

By Len Zehr American CryoStem (OTC:CRYO) has developed platform technologies dedicated to the collection, processing, bio-banking, culturing and differentiation of adipose tissue and adipose derived stem cells (ADSCs)...

September 19, 2017

Feature

BiondVax to start pivotal universal flu vaccine trial next year

By Len Zehr BiondVax Pharmaceuticals (NASDAQ, TASE:BVXV) expects to be Phase 3 ready in 2018 to begin pivotal testing in Europe of a universal flu vaccine with the potential to provide multi-season and multi-strain...

September 12, 2017

Feature

Profound makes leap to platform company from prostate product

By Len Zehr Arun Menawat, CEO With its recent acquisition of Royal Philips’ (NYSE:PHG; AEX:PHIA) Sonalleve business, Profound Medical (OTCQX:PRFMF; TSXV:PRN) is making the leap from a medical device company focused on...

September 5, 2017

Feature

Zymeworks platforms validated by pharma partnerships

By Len Zehr Ali Tehrani, President and CEO Zymeworks’ (NYSE, TSX:ZYME) marquee partnerships with Merck, Eli Lilly, Celgene, GlaxoSmithKline and Daiichi-Sankyo provide validation for its next-generation oncology...

August 29, 2017

Feature

In conversation with Lloyd Segal of Repare

By Len Zehr As president and CEO of upstart Repare Therapeutics, Lloyd Segal was instrumental is arranging the initial funding to create Repare while he served as an entrepreneur-in-residence at Versant Ventures, a...

August 22, 2017

Feature

Contextual Genomics detecting genetic mutations in cancer

By Len Zehr Closely-held Contextual Genomics is giving oncologists a leg up to enhance cancer care with its new Find-It molecular test to detect genetic mutations in cancer patients. “We deliver solutions through our...

August 15, 2017

Feature

CKD patients opt to stay on Dimerix drug after trial

By Len Zehr Forty-five per cent of patients in Dimerix’s (ASX:DXB) successful Phase 2a trial in chronic kidney disease (CKD), on advice from their physician, applied for and were granted access to remain on DMX-200...

August 8, 2017

Feature

Scientus enters commercialization stage of growth, readies launch of lead product

By Len Zehr Closely-held Scientus Pharma expects to launch its first cannabis soft gel capsules for the treatment of neuropathic pain at the end of the year, to be followed in early 2018 with a soft gel for epilepsy and...

August 1, 2017

Category - Feature

Subscribe